Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2021

Jul 23, 2021

30826_dirs_2021-07-22_e430c666-563e-4a60-8fb7-f8f6b36c9c66.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2021-07-13

Reporting Person: DAWES KAREN A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-07-13 Common Stock M 2929 $41.19 Acquired 118982 Direct
2021-07-13 Common Stock S 441 $201.27 Disposed 118541 Direct
2021-07-13 Common Stock S 630 $202.29 Disposed 117911 Direct
2021-07-13 Common Stock S 444 $203.09 Disposed 117467 Direct
2021-07-13 Common Stock S 5 $204.02 Disposed 117462 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-07-13 Stock Option (Right to Buy) $41.19 M 2929 Acquired 2025-07-21 Common Stock (2929) Direct

Footnotes

F1: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F2: $201.27 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.77 to $201.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: $202.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.77 to $202.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: $203.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.86 to $203.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5: $204.02 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.01 to $204.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6: This option is fully vested and exercisable.